SHUNT BALLOON CATHETER HIGH PRESSURE DEB FOR THE TREATMENT OF SHUNT STENOSIS FREEWAY ™ – Shunt DEB protects AV fistulas and shunt grafts from early resteno

FREEWAY ™ – SHUNT BALLOON CATHETER THE COATING MAKES THE DIFFERENCE FREEWAY ™ 035 AV SHUNT – BALLOON CHARACTERISTICS ng/mL • High pressure balloon (rated burst pressure up to 20 atm) • 3μg/mm paclitaxel 2 level of no toxicity reaction • Coating composition of shellac and paclitaxel (1:1 ratio) • Proven safety of coating 1, 2 Amorphous coating The durable non-crystalline bioshell coating homogenously covers the balloon surface and protects the drug from mechanical abrasion and early wash off, resulting in a low paclitaxel blood plasma concentration. Paclitaxel is an active ingredient that inhibits...

HIGH PRESSURE DEB FOR THE TREATMENT OF SHUNT STENOSIS The FREEWAY™ 035 DEB is a clinically proven therapeutical option for AV shunt patients • 4 AV registries show solid results • Reduces re-intervention • Preserves future treatment option 4 Duda S et al. “First experience with DCB in AV-fistulas." Presentation at LINC 2015 5 Troisi N et al. “Freeway paclitaxel-releasing balloons to treat recurrent stenosis of arteriovenous fistula in hemodialysis patients." Minerva cardioangiologica 2018 66(3): 233-237. 6 Cildag MB et al. “The primary patency of drug-eluting balloon versus conventional balloon...

HIGH PRESSURE DEB FOR THE TREATMENT OF SHUNT STENOSIS Eurocor Tech GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Ltd and is part of the Opto Circuits Group. Eurocor Tech GmbH In den Dauen 6a, 53117 Bonn Germany The device fulfils the requirements for CE marking - Notified Body 1434.